1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium has been researched along with cysteine in 1 studies
Studies (1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium) | Trials (1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium) | Recent Studies (post-2010) (1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium) | Studies (cysteine) | Trials (cysteine) | Recent Studies (post-2010) (cysteine) |
---|---|---|---|---|---|
5 | 0 | 1 | 40,132 | 418 | 11,457 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldwin, JJ; Claremon, DA; Doshi, KP; Freund, KF; Gaul, SL; Pitzenberger, SM; Remy, DC; Stern, AM | 1 |
1 other study(ies) available for 1,3-dimethyl-2-((2-oxopropyl)thio)imidazolium and cysteine
Article | Year |
---|---|
Transglutaminase inhibition by 2-[(2-oxopropyl)thio]imidazolium derivatives: mechanism of factor XIIIa inactivation.
Topics: Animals; Binding Sites; Cysteine; Dogs; Erythrocytes; Glutathione; Humans; Hydrogen-Ion Concentration; Imidazoles; Iodoacetamide; Kinetics; Magnetic Resonance Spectroscopy; Molecular Weight; Sulfhydryl Compounds; Transglutaminases | 1994 |